Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (12): 1193-1197.doi: 10.19982/j.issn.1000-6621.20230357
• Review Articles • Previous Articles Next Articles
Dong Yu, Zhang Fuzhen, Shang Yuanyuan, Pang Yu()
Received:
2023-10-09
Online:
2023-12-10
Published:
2023-11-27
Contact:
Pang Yu,Email:Supported by:
CLC Number:
Dong Yu, Zhang Fuzhen, Shang Yuanyuan, Pang Yu. Progress of diagnosis of extrapulmonary tuberculosis with GeneXpert MTB/RIF Ultra[J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1193-1197. doi: 10.19982/j.issn.1000-6621.20230357
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230357
[1] | Mehta PK, Raj A, Singh N, et al. Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol, 2012, 66(1):20-36. doi:10.1111/j.1574-695X.2012.00987.x. |
[2] |
Pang Y, An J, Shu W, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008—2017. Emerg Infect Dis, 2019, 25(3):457-464. doi:10.3201/eid2503.180572.
pmid: 30789144 |
[3] | Acharya B, Acharya A, Gautam S, et al. Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep, 2020, 47(5):4065-4075. doi:10.1007/s11033-020-05413-7. |
[4] | 陆迪雅, 陈澍. T淋巴细胞酶联免疫斑点法在肺外结核诊断中的应用. 中华传染病杂志, 2013, 31(6):377-385. doi:10.3760/cma.j.issn.1000-6680.2013.06.016. |
[5] | 逄宇, 高兴辉, 汤一苇, 等. 基于结核病宿主免疫反应的实验室检测技术及其临床应用. 中国防痨杂志, 2021, 43(9):883-892. doi:10.3969/j.issn.1000-6621.2021.09.006. |
[6] | Goletti D, Delogu G, Matteelli A, et al. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis, 2022, 124 Suppl 1:S12-S19. doi:10.1016/j.ijid.2022.02.047. |
[7] | Shapiro AE, Ross JM, Yao M, et al. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms. Cochrane Database Syst Rev, 2021, 3(3):CD013694. doi:10.1002/14651858.CD013694.pub2. |
[8] | Rindi L. Rapid Molecular Diagnosis of Extra-Pulmonary Tuberculosis by Xpert/RIF Ultra. Front Microbiol, 2022, 13:817661. doi:10.3389/fmicb.2022.817661. |
[9] | Kolia-Diafouka P, Carrère-Kremer S, Lounnas M, et al. Detection of Mycobacterium tuberculosis in paucibacillary sputum: performances of the Xpert MTB/RIF ultra compared to the Xpert MTB/RIF, and IS6110 PCR. Diagn Microbiol Infect Dis, 2019, 94(4):365-370. doi:10.1016/j.diagmicrobio.2019.02.008. |
[10] | Park M, Kon OM. Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosis. Expert Rev Anti Infect Ther, 2021, 19(1):65-77. doi:10.1080/14787210.2020.1810565. |
[11] | 王淑琦, 黄海荣, 王桂荣. Xpert MTB/RIF Ultra与Xpert MTB/RIF检测技术的临床应用及研究进展. 中国防痨杂志, 2018, 40(7):776-780. doi:10.3969/j.issn.1000-6621.2018.07.020. |
[12] |
Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis, 2018, 18(1):76-84. doi:10.1016/S1473-3099(17)30691-6.
pmid: 29198911 |
[13] | 玄琦月, 韩雪, 付英梅. 肺外结核病微生物学诊断方法的研究和应用进展. 生物技术进展, 2021, 11(1):47-53. doi:10.19586/j.2095-2341.2020.0079. |
[14] |
Thao LTP, Heemskerk AD, Geskus RB, et al. Prognostic Models for 9-Month Mortality in Tuberculous Meningitis. Clin Infect Dis, 2018, 66(4):523-532. doi:10.1093/cid/cix849.
pmid: 29029055 |
[15] |
Poplin V, Boulware DR, Bahr NC. Methods for rapid diagnosis of meningitis etiology in adults. Biomark Med, 2020, 14(6):459-479. doi:10.2217/bmm-2019-0333.
pmid: 32270693 |
[16] | Jullien S, Ryan H, Modi M, et al. Six months therapy for tuberculous meningitis. Cochrane Database Syst Rev, 2016, 9(9):CD012091. doi:10.1002/14651858.CD012091.pub2. |
[17] |
Donovan J, Thu DDA, Phu NH, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis, 2020, 20(3):299-307. doi:10.1016/S1473-3099(19)30649-8.
pmid: 31924551 |
[18] |
Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010, 10(11):803-812. doi:10.1016/S1473-3099(10)70138-9.
pmid: 20822958 |
[19] |
Cresswell FV, Tugume L, Bahr NC, et al. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. Lancet Infect Dis, 2020, 20(3):308-317. doi:10.1016/S1473-3099(19)30550-X.
pmid: 31924549 |
[20] |
Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2018, 18(1):68-75. doi:10.1016/S1473-3099(17)30474-7.
pmid: 28919338 |
[21] | Shen Y, Yu G, Zhao W, et al. Efficacy of Xpert MTB/RIF Ultra in diagnosing tuberculosis meningitis: A systematic review and meta-analysis. Medicine (Baltimore), 2021, 100(29):e26778. doi:10.1097/MD.0000000000026778. |
[22] |
Norbis L, Alagna R, Tortoli E, et al. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis. Expert Rev Anti Infect Ther, 2014, 12(5):633-647. doi:10.1586/14787210.2014.899900.
pmid: 24717112 |
[23] | Chen X, Ye J, Lei H, et al. Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study. Front Cell Infect Microbiol, 2022, 12:827528. doi:10.3389/fcimb.2022.827528. |
[24] |
Mohanty M, Mishra B, Jain M, et al. Diagnostic role of Xpert-MTB RIF assay in osteoarticular tuberculosis: A retrospective study. World J Orthop, 2022, 13(3):289-296. doi:10.5312/wjo.v13.i3.289.
pmid: 35317258 |
[25] | Yi L, Li Z, Jiang H, et al. Gene Modification of Transforming Growth Factor β (TGF-β) and Interleukin 10 (IL-10) in Suppressing Mt Sonicate Induced Osteoclast Formation and Bone Absorption. Med Sci Monit, 2018, 24:5200-5207. doi:10.12659/MSM.909720. |
[26] |
Ngcelwane M, Omar SV, Said M, et al. New Horizons in the Diagnosis of Tuberculosis of the Spine: The Role of Whole Genome Sequencing. Asian Spine J, 2023, 17(3):511-517. doi:10.31616/asj.2022.0247.
pmid: 37194130 |
[27] |
Sun Q, Wang S, Dong W, et al. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. J Infect, 2019, 79(2):153-158. doi:10.1016/j.jinf.2019.06.006.
pmid: 31207324 |
[28] | Mekkaoui L, Hallin M, Mouchet F, et al. Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium. PLoS One, 2021, 16(4):e0249734. doi:10.1371/journal.pone.0249734. |
[29] |
Basri Z, Rita AB, Lakhdari A, et al. Lymph node tuberculosis mimicking axillary hidradenitis: a case report. Pan Afr Med J, 2022, 43:98. doi:10.11604/pamj.2022.43.98.33903.
pmid: 36660084 |
[30] | Yu G, Zhong F, Ye B, et al. Diagnostic Accuracy of the Xpert MTB/RIF Assay for Lymph Node Tuberculosis: A Systematic Review and Meta-Analysis. Biomed Res Int, 2019, 2019:4878240. doi:10.1155/2019/4878240. |
[31] | Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, et al. Evaluation of the Xpert MTB/RIF Ultra Assay for Direct Detection of Mycobacterium tuberculosis Complex in Smear-Negative Extrapulmonary Samples. J Clin Microbiol, 2018, 56(9):e00659-18. doi:10.1128/JCM.00659-18. |
[32] |
Antel K, Oosthuizen J, Malherbe F, et al. Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis. BMC Infect Dis, 2020, 20(1):33. doi:10.1186/s12879-019-4749-x.
pmid: 31931736 |
[33] |
Figueiredo AA, Lucon AM, Gomes CM, et al. Urogenital tuberculosis: patient classification in seven different groups according to clinical and radiological presentation. Int Braz J Urol, 2008, 34(4):422-432. doi:10.1590/s1677-55382008000400004.
pmid: 18778493 |
[34] |
Muneer A, Macrae B, Krishnamoorthy S, et al. Urogenital tuberculosis-epidemiology, pathogenesis and clinical features. Nat Rev Urol, 2019, 16(10):573-598. doi:10.1038/s41585-019-0228-9.
pmid: 31548730 |
[35] | López-Roa P, Martin-Higuera C, Ruiz-Serrano MJ, et al. Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence. Diagn Microbiol Infect Dis, 2021, 99(2):115235. doi:10.1016/j.diagmicrobio.2020.115235. |
[36] | Opota O, Mazza-Stalder J, Greub G, et al. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect, 2019, 25(11):1370-1376. doi:10.1016/j.cmi.2019.03.021. |
[1] | Zhao Yanli, Che Nanying. Interpretation of social organization standard of Specification for Pathological Diagnosis of Tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 371-374. |
[2] | Xu Chenyi, Chen Hui, Zhong Jiyuan, Ding Xiaoyan, Yang Rui, Xu Xiangchao, Zhang Canyou, Cheng Jun, Li Tao. Investigation on the status of tuberculosis infection among household student close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 375-382. |
[3] | Chen Ruiqi, Zhang Mingwu, Wang Wei, Chen Songhua, Liu Zhengwei, Chen Bin. Prevalence and influencing factors of latent tuberculosis infection among elderly rural residents in Changshan County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 383-389. |
[4] | Fan Xiaolei, Maiwulajiang·Yimamu , Peng Xiaowang, Hu Pengyuan, Wang Yanjie, Alimire·Abulimiti , Mairihaba·Kamili , Wang Senlu, Xiang Yang. Analysis of the incidence and influencing factors of household close contacts of pulmonary tuberculosis patients in Kashgar, Xinjiang Uygur Autonomous Region, 2018—2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 390-396. |
[5] | Teng Chong, Wang Yulan, Liu Liu, Zhang Fang, Huang Fei, Li Tao, Zhao Bing, Zhao Yanlin, Ou Xichao. Analysis of the epidemiological characteristics and prediction for the reported incidence of pulmonary tuberculosis in Dongcheng District, Beijing from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 397-402. |
[6] | Yang Chao, Wang Jing, Yang Chaohui, Gao Hanqing. Analysis of the epidemiological characteristics and treatment outcomes of pulmonary tuberculosis aged ≥60 years old in Tongzhou District of Beijing, 2016—2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 403-410. |
[7] | Li Xueqiu, Kuang Haobin, Wang Ting, Min Fei, Tao Lan, Cao Xihui, Li Xiang, Liu Guobiao. Analysis of self-paid medical expenses and influencing factors for multidrug-resistant tuberculosis patients in Guangzhou City [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 411-417. |
[8] | Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin. Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423. |
[9] | Zhou Shuang, Zong Di, Li Shixue, Du Jian. Analysis of influencing factors of tuberculosis patients’ medical experience with the internet hospital platform [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 424-432. |
[10] | Ni Shuaihu, Wang Jia, Chen Gang, Dong Longyu, Wang Ni, Luo Xiaofeng, Qu Yan, ZhaoYanlin . Analysis of the influence of receiving health education on knowledge, belief and behavior of college students in four provinces in China [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 433-439. |
[11] | Li Yang, Chen Bin, Peng Ying, Chen Xinyi, Jiang Jianmin. Investigation and analysis of social discrimination and awareness of pulmonary tuberculosis among junior college students in Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 440-448. |
[12] | Shang Xuetian, Dong Jing, Huang Mailing, Sun Qi, Jia Hongyan, Zhang Lanyue, Liu Qiuyue, Yao Mingxu, Wang Yingchao, Ji Xiuxiu, Du Boping, Xing Aiying, Pan Liping. Transcriptome study on peripheral blood mononuclear cells of latent tuberculosis infection individuals [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 449-460. |
[13] | Zheng Hailun, Li Yamin, Sun Shanhua, He Xiaoxin. Analysis of influencing factors on treatment interruption in 317 pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 467-472. |
[14] | Song Ruixue, Yao Mingxu, Pan Liping. Research progresses of interferon-induced protein 10 in the diagnosis and monitor of respiratory infectious diseases [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 473-478. |
[15] | Wen Shufang, Wei Rongrong, Li Haoran, Liu Yi. The role of CD4+ and CD8+T cells in the immune response to tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 479-484. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||